[go: up one dir, main page]

JPS6256136B2 - - Google Patents

Info

Publication number
JPS6256136B2
JPS6256136B2 JP54142152A JP14215279A JPS6256136B2 JP S6256136 B2 JPS6256136 B2 JP S6256136B2 JP 54142152 A JP54142152 A JP 54142152A JP 14215279 A JP14215279 A JP 14215279A JP S6256136 B2 JPS6256136 B2 JP S6256136B2
Authority
JP
Japan
Prior art keywords
antitumor
antibody
tumor
substance
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54142152A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5665828A (en
Inventor
Chikao Yoshikumi
Takami Fujii
Masahiko Fujii
Kenichi Matsunaga
Yoshiharu Oguchi
Koichi Niimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Priority to JP14215279A priority Critical patent/JPS5665828A/ja
Priority to US06/103,474 priority patent/US4315851A/en
Priority to SE7910483A priority patent/SE7910483L/xx
Priority to PH23447A priority patent/PH16902A/en
Priority to FR797932054A priority patent/FR2445149B1/fr
Priority to CH11501/79A priority patent/CH655010A5/de
Priority to GB7944494A priority patent/GB2038836B/en
Priority to DE2952690A priority patent/DE2952690C2/de
Priority to IT28464/79A priority patent/IT1127324B/it
Publication of JPS5665828A publication Critical patent/JPS5665828A/ja
Priority to US06/321,486 priority patent/US4401592A/en
Priority to SE8406510A priority patent/SE8406510D0/xx
Priority to SE8406511A priority patent/SE8406511D0/xx
Publication of JPS6256136B2 publication Critical patent/JPS6256136B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP14215279A 1978-12-29 1979-11-02 Antitumor agent Granted JPS5665828A (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
JP14215279A JPS5665828A (en) 1979-11-02 1979-11-02 Antitumor agent
US06/103,474 US4315851A (en) 1978-12-29 1979-12-14 Pharmaceutical composition having antitumor activity
SE7910483A SE7910483L (sv) 1978-12-29 1979-12-19 Farmaceutisk komposition med tumorhemmande effekt
PH23447A PH16902A (en) 1978-12-29 1979-12-20 Pharmaceutical composition having anti-tumor activity
FR797932054A FR2445149B1 (fr) 1978-12-29 1979-12-28 Composition pharmaceutique ayant une activite antitumorale
CH11501/79A CH655010A5 (de) 1978-12-29 1979-12-28 Pharmazeutischer wirkstoff mit antitumoraktivitaet.
GB7944494A GB2038836B (en) 1978-12-29 1979-12-28 Antitumour substance
DE2952690A DE2952690C2 (de) 1978-12-29 1979-12-29 Antitumorsubstanz, Verfahren zu ihrer Herstellung und diese enthaltendes pharmazeutisches Mittel
IT28464/79A IT1127324B (it) 1978-12-29 1979-12-31 Composizione farmaceutica avente attivita' antitumorale
US06/321,486 US4401592A (en) 1978-12-29 1981-11-16 Pharmaceutical composition having antitumor activity
SE8406510A SE8406510D0 (sv) 1978-12-29 1984-12-20 Farmaceutisk komposition med tumorhemmande effekt
SE8406511A SE8406511D0 (sv) 1978-12-29 1984-12-20 Farmaceutisk komposition med tumorhemmande effekt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14215279A JPS5665828A (en) 1979-11-02 1979-11-02 Antitumor agent

Publications (2)

Publication Number Publication Date
JPS5665828A JPS5665828A (en) 1981-06-03
JPS6256136B2 true JPS6256136B2 (fr) 1987-11-24

Family

ID=15308563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14215279A Granted JPS5665828A (en) 1978-12-29 1979-11-02 Antitumor agent

Country Status (1)

Country Link
JP (1) JPS5665828A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0470125U (fr) * 1990-10-25 1992-06-22

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58118520A (ja) * 1982-01-09 1983-07-14 Hidematsu Hirai 抗腫瘍性蛋白複合体およびその製造法
JPH0653682B2 (ja) * 1983-04-08 1994-07-20 呉羽化学工業株式会社 ヒト免疫グロブリン結合抗腫瘍剤

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4962194A (fr) * 1972-05-10 1974-06-17
JPS5161640A (en) * 1974-09-20 1976-05-28 Searle & Co Koshuyozaino seizoho
JPS51144723A (en) * 1975-05-27 1976-12-13 Yeda Res & Dev Antiitumor agent
JPS5592325A (en) * 1978-12-29 1980-07-12 Kureha Chem Ind Co Ltd Antitumor agent and its preparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4962194A (fr) * 1972-05-10 1974-06-17
JPS5161640A (en) * 1974-09-20 1976-05-28 Searle & Co Koshuyozaino seizoho
JPS51144723A (en) * 1975-05-27 1976-12-13 Yeda Res & Dev Antiitumor agent
JPS5592325A (en) * 1978-12-29 1980-07-12 Kureha Chem Ind Co Ltd Antitumor agent and its preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0470125U (fr) * 1990-10-25 1992-06-22

Also Published As

Publication number Publication date
JPS5665828A (en) 1981-06-03

Similar Documents

Publication Publication Date Title
US4315851A (en) Pharmaceutical composition having antitumor activity
US4738843A (en) Anti-tumor substance of immunoglobulin and melphalan and process for producing the same
US4350626A (en) Antitumor hybrid and process for the preparation thereof
US4376765A (en) Medicaments, their preparation and compositions containing same
JP2001500528A (ja) 新規糖タンパク質
JPH02256700A (ja) 細胞毒性薬物コンジュゲート
JPH02131499A (ja) 細胞毒性薬物コンジュゲートおよびその製法
FR2516794A1 (fr) Nouveaux medicaments anticancereux pour le traitement des leucemies t constitues de la chaine a de la ricine et d'un anticorps monoclonal specifique
CA1242982A (fr) Derives immunostimulants et leur procede de preparation
HU210147B (en) Process for producing antibody-drug conjugates and pharmaceutical compositions containing them
JPH07223969A (ja) チオエーテル結合体の製造法
US5672688A (en) Immunoglobulin Fc fragment bound to an alkylating, antibiotic, or antimetabolic antitum or substance
JPS6254086B2 (fr)
JPS6256136B2 (fr)
BE882541A (fr) Nouvelles formes pharmaceutiques leur preparation et les compositions qui les contiennent
EP1289563B1 (fr) Méthode de conditionnement d'une colonne à matrice avidine ou streptavidine dans un dispositif extracorporel
US20040052784A1 (en) Biotin derivatives
JPS6256137B2 (fr)
US4895872A (en) Immunosupressive analogues and derivatives of succinylacetone
JPH0133119B2 (fr)
JPH08509698A (ja) 蛋白質複合体、それを含む組成物及びその医薬としての用途
JPH0651643B2 (ja) 殺細胞性修飾免疫グロブリン及びその製造方法
JPH01199573A (ja) スーパーオキシドジスムターゼ誘導体およびその製造法
CA2121990A1 (fr) Conjugues anticorps-medicament
AU626087B2 (en) Improved immunotoxin therapies utilizing purified ricin a-chain species